Association Between SYNTAX Score and Leukoglycemic Index In Patients Wiht Acute Coronary Syndrome
1 other identifier
observational
552
1 country
1
Brief Summary
This study looks at people who come to the hospital with acute coronary syndrome, a serious heart condition. When these patients first arrive, doctors take routine blood tests. The investigators use these test results to calculate a value called the leukoglycemic index (LGI), which combines white blood cell count and blood sugar level. The investigators also use a heart imaging score called the SYNTAX score to see how complex their coronary artery disease is. Patients are divided into two groups based on their SYNTAX scores: one group with lower scores (22 or less), and one with higher scores (above 22). The investigators compare their health data to see if LGI is linked to the severity of their heart disease. The investigators also check if LGI can help predict how complex the disease is. Information like age, family history, and chronic illnesses is collected from patient records and medical interviews.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2025
CompletedFirst Submitted
Initial submission to the registry
November 28, 2025
CompletedFirst Posted
Study publicly available on registry
December 11, 2025
CompletedResults Posted
Study results publicly available
February 25, 2026
CompletedFebruary 25, 2026
December 1, 2025
27 days
November 28, 2025
December 15, 2025
February 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Leukoglycemic Index (LGI)
The LGI is calculated as the product of blood glucose concentration (mg/dL) and leukocyte count (cells/mm³). This composite measure provides a single numerical value that reflects both metabolic status (via blood glucose) and hematological status (via white blood cell count). At baseline, LGI serves as an integrated indicator of participants' metabolic and immune activity. It is simple to compute and offers a practical way to capture two fundamental aspects of health in one measure. Higher values are considered worse outcomes because they reflect an increased metabolic and inflammatory burden
First day
Study Arms (2)
SYNTAX score =<22
SYNTAX score >22
Interventions
leukoglycemic index calculation
Eligibility Criteria
Patients with acute coronary syndrome
You may qualify if:
- Adult patients aged 18 years and older
- Patients who underwent coronary angiography due to acute coronary syndrome
You may not qualify if:
- Patients with diabetes mellitus (Diagnosis based on current use of oral antidiabetic or insulin therapy and/or fasting glucose level ≥126 mg/dL and HbA1c ≥6.5%)
- Patients with atrial fibrillation, history of pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease
- Obese individuals (defined as body mass index \[BMI\] \>30 kg/m²)
- Patients whose medical records could not be accessed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kırıkkale university
Kırıkkale, Kırıkkale, 71000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
There was no limitation about the study
Results Point of Contact
- Title
- Rukiye GONEN OZDEMIR
- Organization
- Kırıkkale University, Faculty of Medicine, Department of Cardiology
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
November 28, 2025
First Posted
December 11, 2025
Study Start
September 24, 2025
Primary Completion
October 21, 2025
Study Completion
October 21, 2025
Last Updated
February 25, 2026
Results First Posted
February 25, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share